(Q36989937)

17 August 2017

Serum vitamin D concentration and prostate cancer risk: a nested case-control study (English)

1 reference

17 August 2017

0 references

1 reference

4

1 reference

17 August 2017

5

1 reference

17 August 2017

3

Demetrius Albanes

1 reference

17 August 2017

Jiyoung Ahn

1

0 references

Richard B Hayes

object named as

Richard B Hayes

11

0 references

Nilanjan Chatterjee

6

object named as

Nilanjan Chatterjee

1 reference

17 August 2017

2

Ulrike Peters

1 reference

17 August 2017

8

Bruce W Hollis

1 reference

17 August 2017

Ronald L Horst

7

1 reference

17 August 2017

Wen-Yi Huang

9

1 reference

17 August 2017

James M Shikany

10

1 reference

17 August 2017

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team

12

1 reference

17 August 2017

language of work or name

English

0 references

publication date

27 May 2008

1 reference

Journal of the National Cancer Institute

17 August 2017

1 reference

17 August 2017

100

1 reference

17 August 2017

796-804

1 reference

17 August 2017

11

1 reference

Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

The pleiotropic actions of vitamin D.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Mechanisms and functions of vitamin D.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Methods for etiologic and early marker investigations in the PLCO trial.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Residential sunlight exposure is associated with a decreased risk of prostate cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703748

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN152

Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers

21 January 2018

1 reference

12 December 2020

Stability of vitamin D metabolites in human blood serum and plasma

1 reference

12 December 2020

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer

1 reference

12 December 2020

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk

1 reference

12 December 2020

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

12 December 2020

Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJN152

1 reference

17 August 2017

1 reference

17 August 2017

1 reference